Search details
1.
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.
EBioMedicine
; 98: 104878, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38016322
2.
Nonhuman primate models for evaluation of SARS-CoV-2 vaccines.
Expert Rev Vaccines
; 21(8): 1055-1070, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35652289
Results
1 -
2
de 2
1
Next >
>>